Our Services and Platform Technologies
RxCelerate offers world class platform technologies and services from early in silico discovery through to preclinical studies.
Integrated Services Spanning Drug Discovery & Development
Our Platform Technologies
Our proprietary technologies give a unique advantage to your drug discovery project.
Metastate discovery platform
Leveraging advanced molecular dynamics, RxPlorer™ uncovers protein metastates and reveals novel binding sites in difficult to target proteins.
Dynamic Chemical Space
First commercially available dynamic chemical space allowing in silico screening of billions of novel small molecules against a target in a matter of weeks.
Antibody Discovery Platform
Proprietary human antibody discovery platform, which combines the biology of B-cell selection and in vitro methodologies to maximise diversity and find high quality leads.
Proteomics Platform
Unique proteomics platform offering quantitative precision and unbiased analysis of proteins and their modifications in simple and complex matrices.
Why work with us?
- Bespoke programmes built from first principles, aligned to the scientific goals
- Cutting-edge technologies to de-risk and accelerate development
- Integrated services for smarter, faster decision-making
- Experienced teams for different target classes and therapeutic areas
- Proven track record including first-in-class programmes
Our Approach
We design and deliver fully customised discovery and development programmes shaped around your scientific goals. Our flexible operating model and expert teams provide the support needed for rapid and reliable decision making. We work as an extension of your team to support the successful progression of your assets, from concept to clinic.
Our track record includes multiple biotechs and venture-backed companies progressing to clinical development through our partnership-driven approach.
RxCelerate offers a unique business model catering to both small molecules and biologics. We work with you to drive your asset through drug discovery, preclinical research and beyond.
Unlike many contract research organisations (CROs) that rely on standardised, off-the-shelf assays, our scientific solutions include custom assays and models, built from first principles. Our combination of integrated teams and unique technologies allows RxCelerate to develop the optimal drug discovery strategy to deliver pharma-grade drug candidates quickly and at a fraction of the cost of traditional CRO approaches.